IDEA-FAST F2F Meeting Kiel


Monday, 18 November 2019
1.00 – 1.30 p.m.Get together (incl. drinks & snacks)
1.30 – 2.30 p.m.Welcome Address1:30 Fai Ng: Introduction1:50 Emilio Merlo Pich / Stefan Avey: EFPIA perspective2:10 Walter Maetzler: Aims of the meeting & introduction to working groups
2.30 – 4.00 p.m.Discussion in four groupsA) Clinical assessmentAspects include: Feasibility study assessments, qualitative research, PSG subcohortB) Device criteriaAspects include: CE-certified devices, time period over which devices will be used, possible combinations of devicesC) Existing datasets & data platformsAspects include: Use of existing datasets for shaping the feasibility study and the clinical study, timeline of data platform creationD) Ethics, regulatory aspects & data protectionAspects include: Feasibility of timeline for ethics submission, ethical considerations for clinical assessments, regulatory considerations including efforts to keep the study “observational” rather than a “device-study” (MHRA approval would slow down the project)
4.00 – 4.30 p.m.Coffee break
4.30 – 6.00 p.m.Collection of results from discussion in four groups
(for presentation on Tuesday)
Tuesday, 19 November 2019
8.30 –10.30 a.m.Presentation & discussion of group results with all participants8.30     A) Clinical assessment9.00     B) Device criteria9.30     C) Existing datasets & data platforms10.00   D) Ethics & data protection
10.30 – 11.00 a.m.Coffee break
11.00 – 12.00 a.m.From Vision to Practice: the first 18 months of IDEA-FAST (including logistics of running the studies)
12.30 – 1.00 p.m.Summary and Farewell (Fai Ng)



November 18, 2019
1:00 pm


November 19, 2019
1:00 pm


Universitätsklinikum Schleswig-Holstein


Universitätsklinikum Schleswig-Holstein, Kiel, Germany